A detailed history of River Street Advisors LLC transactions in Amgen Inc stock. As of the latest transaction made, River Street Advisors LLC holds 594 shares of AMGN stock, worth $162,405. This represents 0.1% of its overall portfolio holdings.

Number of Shares
594
Previous 594 -0.0%
Holding current value
$162,405
Previous $186 Million 3.12%
% of portfolio
0.1%
Previous 0.11%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$262.75 - $319.31 $156,073 - $189,670
594 New
594 $186 Million
Q4 2022

Feb 08, 2023

BUY
$229.03 - $291.01 $188,491 - $239,501
823 New
823 $216 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $146B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track River Street Advisors LLC Portfolio

Follow River Street Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of River Street Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on River Street Advisors LLC with notifications on news.